Asymchem is a global CDMO that has consistently innovated and invested in new technologies to stay on the forefront of trends in both R&D and production since its inception in 1999. As a result, Asymchem is well-positioned and structured to be a true global partner in drug development and manufacturing for pharmaceutical and biotech companies by offering integrated solutions across all stages of drug development and into commercialization.
